Here we report on the discovery of NOA2, a human monoclonal antibody that targets CD99 and is capable of recruiting and reactivating components of the innate immune system to direct antibody-mediated Ewing sarcoma death. This evidence concerns the gene CD99 and Ewing sarcoma.